Lawrence G. Hamel
2013
In 2013, Lawrence G. Hamel earned a total compensation of $891.5K as Chief Development Officer at AcelRx Pharmaceuticals, a 73% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,520 |
|---|---|
| Option Awards | $458,346 |
| Salary | $301,000 |
| Other | $7,650 |
| Total | $891,516 |
Hamel received $458.3K in option awards, accounting for 51% of the total pay in 2013.
Hamel also received $124.5K in non-equity incentive plan, $301K in salary and $7.7K in other compensation.
Rankings
In 2013, Lawrence G. Hamel's compensation ranked 7,153rd out of 12,286 executives tracked by ExecPay. In other words, Hamel earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,153 out of 12,286 | 42nd |
Division Manufacturing | 2,549 out of 4,612 | 45th |
Major group Chemicals And Allied Products | 788 out of 1,462 | 46th |
Industry group Drugs | 588 out of 1,156 | 49th |
Industry Pharmaceutical Preparations | 465 out of 890 | 48th |
Source: SEC filing on April 28, 2016.
Hamel's colleagues
We found five more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2013.
2013
Richard King
AcelRx Pharmaceuticals
Chief Executive Officer
2013
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
2013
David Chung
AcelRx Pharmaceuticals
Chief Commercial Officer
2013
James Welch
AcelRx Pharmaceuticals
Chief Financial Officer
2013
Badri Dasu
AcelRx Pharmaceuticals